Curis (CRIS) EBT Growth (1y) (2011 - 2026)
Curis (CRIS) EBT Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
-88.68% |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
13.34% |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
-51.60% |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
-313.33% |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
-79.57% |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
-230.18% |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
71.54% |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Curis |
8.58 Mn |
-6.42 Mn |
- |
-7.78% |
| Date | Value |
|---|
| Mar 31, 2026 |
-7.78% |
| Dec 31, 2025 |
301.25% |
| Sep 30, 2025 |
23.41% |
| Jun 30, 2025 |
27.20% |
| Mar 31, 2025 |
10.61% |
| Dec 31, 2024 |
17.88% |
| Sep 30, 2024 |
17.15% |
| Jun 30, 2024 |
1.32% |
| Mar 31, 2024 |
-2.74% |
| Dec 31, 2023 |
-3.38% |
| Sep 30, 2023 |
8.37% |
| Jun 30, 2023 |
24.96% |
| Mar 31, 2023 |
28.25% |
| Dec 31, 2022 |
16.82% |
| Sep 30, 2022 |
-20.30% |
| Jun 30, 2022 |
-35.91% |
| Mar 31, 2022 |
-62.27% |
| Dec 31, 2021 |
-81.19% |
| Sep 30, 2021 |
-84.98% |
| Jun 30, 2021 |
-74.81% |
